CHEN, YANYUN,MEZO, ADAM ROBERT,QU, HONGCHANG,VALENZUELA, FRANCISCO ALCIDES
申请号：
CA2987489
公开号：
CA2987489A1
申请日:
2016.06.16
申请国别(地区):
CA
年份:
2016
代理人:
摘要：
The present invention provides glucagon and GLP-1 co-agonist compounds that are useful in the treatment of type 2 diabetes, obesity, nonalcoholic fatty liver disease (NAFLD) and/or nonalcoholic steatohepatitis (NASH). P-20637
